MARKET

ARDX

ARDX

Ardelyx
NASDAQ
3.910
-0.060
-1.51%
After Hours: 3.919 +0.009 +0.24% 17:15 08/13 EDT
OPEN
4.030
PREV CLOSE
3.970
HIGH
4.040
LOW
3.860
VOLUME
4.33M
TURNOVER
--
52 WEEK HIGH
8.40
52 WEEK LOW
3.860
MARKET CAP
974.32M
P/E (TTM)
-17.2932
1D
5D
1M
3M
1Y
5Y
1D
Ardelyx Q2: Strong Demand, But Payer Friction Clouds The Story
Seeking Alpha · 1d ago
Ardelyx Price Target Cut to $11.00/Share From $14.00 by Citigroup
Dow Jones · 3d ago
Ardelyx Is Maintained at Buy by Citigroup
Dow Jones · 3d ago
Citigroup Maintains Buy on Ardelyx, Lowers Price Target to $11
Benzinga · 3d ago
Ladenburg Thalmann & Co. Remains a Buy on Ardelyx (ARDX)
TipRanks · 3d ago
Analysts Are Bullish on These Healthcare Stocks: Immix Biopharma (IMMX), Ardelyx (ARDX)
TipRanks · 3d ago
Weekly Report: what happened at ARDX last week (0803-0807)?
Weekly Report · 3d ago
Ardelyx Price Target Cut to $10.00/Share From $13.00 by TD Cowen
Dow Jones · 6d ago
More
About ARDX
Ardelyx, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. The Company markets two therapies from the active ingredient tenapanor, a sodium/hydrogen exchanger (NHE3) inhibitor. Tenapanor, branded as IBSRELA, is approved in the United States for the treatment of adults with irritable bowel syndrome with constipation (IBS-C). Tenapanor, branded as XPHOZAH, is approved in the United States to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. It is also developing a next-generation NHE3 inhibitor, RDX10531, which has demonstrated in preclinical models to have improved solubility and potency compared to tenapanor. RDX10531 has applications across multiple therapeutic areas.

Webull offers Ardelyx Inc stock information, including NASDAQ: ARDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARDX stock methods without spending real money on the virtual paper trading platform.